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Abstract
We characterized tumor microenvironment (TME) components of mobile ton-
gue (MT) cancer patients in terms of overall inflammatory infiltrate, focusing
on the protumorigenic/anti-inflammatory phenotypes and on cancer-associated
fibroblasts (CAFs) in order to determine their interrelations and associations
with clinical outcomes. In addition, by culturing tongue carcinoma cells (HSC-
3) on a three-dimensional myoma organotypic model that mimics TME, we
attempted to investigate the possible existence of a molecular crosstalk between
cancer cells and TME components. Analysis of 64 cases of MT cancer patients
revealed that the overall density of the inflammatory infiltrate was inversely
correlated to the density of CAFs (P = 0.01), but that the cumulative density of
the protumorigenic/anti-inflammatory phenotypes, including regulatory T cells
(Tregs, Foxp3+), tumor-associated macrophages (TAM2, CD163+), and poten-
tially Tregs-inducing immune cells (CD80+), was directly correlated with the
density of CAFs (P = 0.01). The hazard ratio (HR) for recurrence in a TME
rich in CD163+ Foxp3+ CD80+ was 2.9 (95% CI 1.03–8.6, P = 0.043 compared
with low in CD163+ Foxp3+ CD80+). The HR for recurrence in a TME rich in
CAFs was 4.1 (95% confidence interval [CI] 1.3–12.8, P = 0.012 compared
with low in CAFs). In vitro studies showed cancer-derived exosomes, epithelial
–mesenchymal transition process, fibroblast-to-CAF-like cell transdifferentia-
tion, and reciprocal interrelations between different cytokines suggesting the
presence of molecular crosstalk between cancer cells and TME components.
Collectively, these results highlighted the emerging need of new therapies target-
ing this crosstalk between the cancer cells and TME components in MT cancer.
Introduction
Over 400,000 new cases of oral cancer are expected to be
diagnosed worldwide each year, and >50% are cancers of
the mobile/oral tongue (MT) [1, 2]. Despite advances in
surgery, radiotherapy, and chemotherapy treatment, the
mortality rate has remained essentially unchanged for the
last four decades, with a 5-year survival rate of around
50% [3]. The incidence of MT cancer is currently
reported to be increasing compared with other head and
neck sites, especially in the 20- to 44-year age group [4,
5]. We recently showed that components of the tumor
microenvironment (TME) have a cardinal role in the
molecular biology of MT cancer in terms of the invasion
and spread of the tumors, with a direct impact on
patients’ clinical outcomes [5]. Specifically, we found that
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the cancer-associated fibroblasts (CAFs) have a negative
impact on overall and specific survival [6, 7]. In addition,
we provided evidence that CAFs were present in the
metastatic lymph nodes similarly to matched primary
tongue tumors, thus suggesting that CAFs not only
promote tumor invasion but also facilitate metastasis [8].
The inflammatory infiltrate of a TME is an essential
source of cytokines, chemokines, growth factors, angio-
genic factors, and enzymes [9–11]. These are produced
and released in considerable amounts by certain types of
inflammatory cells that were shown to be implicated in
tumor growth, progression, and invasion in human colon
and breast cancer [9, 10]. As such, these protumorigenic
inflammatory cells comprise “bad inflammation,” in
contrast to components of the inflammatory infiltrate that
represent an antitumorigenic force and, therefore, consti-
tute “good inflammation” [9]. Furthermore, the molecu-
lar interactions between the inflammatory infiltrate and
other components of TME (e.g., CAFs) are assumed to be
of special importance in view of the finding that CAFs
can express inflammation-related genes and correspond-
ing protein products [12, 13]. In oral cancer, the general
notion is that the more abundant the inflammatory infil-
trate surrounding the tumor, the better the prognosis of
the patients [14, 15], but there has been very little
in-depth analysis of the inflammatory infiltrate. One
recent study associated the frequency of the regulatory T
cells with a lower grade of histological differentiation
[16]. In another study in which cases of squamous cell
carcinoma (SCC) of the oral cavity were analyzed
together with cancers of the oropharynx, hypopharynx,
epilarynx, and larynx, it was reported that regulatory T
cells (bearing a Foxp3+ CD4+ phenotype) were positively
correlated with locoregional control [17]. The newly
recognized differences in etiology, epidemiology, and
clinical outcomes of the tumors in the oral cavity
compared with those of the oropharynx and larynx
called for re-evaluation of previously published conclu-
sions [17]. Moreover, a very recent study on oral SCC
cases demonstrated a positive correlation between tumor-
associated macrophages (TAM) of the M2 (TAM2) pheno
type and CAFs and poor prognosis [18]. However, no
study has specifically examined the overall inflammatory
infiltrate in MT cancer or the constituent inflammatory
cell types, or looked into how this inflammatory infiltrate
relates to CAFs and to clinical outcomes.
It was the aim of this study to delineate the profile of the
inflammatory infiltrate in a TME of MT cancer, with
emphasis on the protumorigenic components, and to assess
their interrelations with CAFs. We also analyzed how all
these elements were associated with clinical outcomes.
In addition, using a new in vitro three-dimensional myoma
organotypic model [19], we investigated the possible
occurrence of pathways of molecular crosstalk between
cancer cells and various TME components in order to pro-
vide new candidate molecular therapeutic targets.
Materials and Methods
MT cancer patients
Sections from resection specimens of a total 64 patients
with MT cancer were used in this study, 31 females (mean
age 65 ± 11.7 years) and 33 males (mean age
57.4 ± 17.9 years). The patients were staged according to
the 1997 International Union Against Cancer classification
(TNM), where stages I and II were considered early-stage
(n = 15) patients and stages III and IV as late-stage
(n = 49) patients. None of the patients was previously
treated, all had undergone surgery, and complementary
radiotherapy (n = 32), radio- and chemotherapy (n = 10),
or only chemotherapy (n = 1) was administered when
indicated. All patients were treated at the Chaim Sheba
Medical Center, Tel Hashomer, Israel, between 1990 and
2006. The study was approved by the IRB of the medical
center. Ten patients with no evidence of disease (NED)
who were followed for less than 18 months were deleted
from the survival analysis. For the remaining 54 patients,
the mean follow-up was 63 ± 43 months. The clinical
outcomes were measured by two endpoints: locoregional
disease control expressed by locoregional recurrence (LR)
and overall survival (OS). Time to recurrence was calcu-
lated as the interval between the date of diagnosis and the
first sign of treatment failure at the primary tumor site, at
the site of cervical metastases, or both. The OS calculation
included patients alive and free of disease and those alive
with disease at the last follow-up visit.
TME components in the specimen sections
Inflammatory infiltrate
Morphometrical density (hematoxylin and eosin–
stained slides)
Assessment was performed throughout the tumor section
at the TME interface in each case and it was classified as
1 = absent or limited, 2 = dense but intermittent, and
3 = dense and continuous infiltrate around the tumor.
Immunohistochemistry and immunomorphometry
of inflammatory cells and nuclear factor kappa-B
The antibodies used to identify the various classes of
inflammatory cells and nuclear factor kappa-B (NF-jB)
and the essentials of preparations of the immunostains
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are included in the supplemental material. The percentage
of the positively stained cells from the entire population
of inflammatory cells was assessed for each staining in
each case. Positive staining of the CD80+ cells included
the inflammatory and spindle-shaped CAF-like cells
within the TME. Similar to the CD80+ cells, positive
staining of CD163 cells included the inflammatory spin-
dle-shaped CAF-like cells and the endothelial cells within
the TME. For survival analysis, each of the results
(presented as percentages of positively stained cells) was
classified into “low” and “high” groups, with the median
value considered the cutoff point (i.e., low  median
and high > median). In addition, we further converted
the results expressed as percentages to a scoring system
(described below).
Foxp3-stained cells were relatively sparse and were
therefore scored semi-quantitatively on a scale from 0 to 4:
0 = no stained cells, 1 = a few dispersed cells, 2 = similar
to “1” with the addition of small foci consisting of <10
cells, and 3 = similar to “2” with foci comprising >10 cells.
For survival analysis, Foxp3 was grouped into low score
(scores of 0, 1, and 2) versus a high score (a score of 3).
The results that were expressed as percentages of the
positively stained inflammatory cells were converted to the
following scoring system for comparisons in the statistical
analysis: 1 =  10% positive cells, 2 = 11–25% positively
stained cells, 3 = 26–75% positive cells, and 4 = >75%
positively stained cells. Using this system, and being inter-
ested in detecting possible associations between the addi-
tive impacts of the TME cells with an anti-inflammatory/
protumorigenic function and the clinical outcomes, we
combined the scores of CD80+ Foxp3+ CD163+. In this
way, we were able to arrive at the cumulative score of
the cells that represented the unified anti-inflammatory/
protumorigenic forces within the TME of MT cancer. The
results of the scoring system for each individual stain as
well as for the cumulative scores were expressed as mean
(±SD) and median scores. For purposes of statistical anal-
yses, the median score served as the cutoff point, where
mean scores equal to or less than the median were consid-
ered low and those higher than the median as high.
NF-jB staining was assessed as the percent of positive
inflammatory cells from the total of inflammatory cells. NF-
jB was considered being positive when it was identified in
both the nuclear and cytoplasmic cellular compartments
due to the occurrence of cytoplasmic-nuclear shuttling [20].
Appropriate positive and negative controls were applied
for all the described immunohistochemical procedures.
Cancer-associated fibroblasts
CAFs, as identified by a-smooth muscle actin (a-SMA),
were assessed as previously described [6] using a 5-scale
scoring system: 0 = absent, 0.5 = a few spindle-shaped
CAFs at the periphery of the SCC, 1 = CAFs surrounding
the tumor in a few concentric layers in several foci,
2 = CAFs with both spindle-shaped and plump morpho-
logy in many areas of the tumor, and 3 = similar to “2” but
CAFs exceptionally abundant throughout the section, occa-
sionally exceeding the carcinomatous component [6, 7].
For statistical survival analysis, the a-SMA-stained CAFs
were classified into CAF poor-to-intermediate (scores of 0,
0.5, 1, and 2) versus CAF-rich (a score of 3) groups.
Staining of the tumor cells
In addition, the percentages of the CD80+ and the NF-jB+
tumor cells from the entire tumor mass were assessed.
In vitro three-dimensional myoma
organotypic model
Tongue SCC cells were cultured on the disks of an in vitro
three-dimensional myoma organotypic model as previ-
ously described [19]. The reason for using this model was
its advantage in approximating the natural TME in both
the variety of the cellular components and the presence of
various extracellular matrix proteins and glycoproteins
[19]. Briefly, uterine leiomyoma tissue was retrieved from
routine surgical operations after obtaining informed con-
sent of the donors. (The study was approved by the Ethics
Committee of the Oulu University Hospital, Oulu, Fin-
land.) Four-millimeter-thick, 8-mm-diameter myoma disks
were prepared and stored at 70°C in cell culture media
with 10% fetal bovine serum (FBS). To prepare myoma-
based organotypic cultures, myoma disks were equilibrated
in culture medium at room temperature for 1 h, after
which cancer cells were added on top of each disk. Human
tongue SCC cells HSC-3 (JCRB 0623; Osaka National
Institute of Health Sciences, Osaka, Japan) were cultured
in 1:1 Dulbecco’s modified Eagle’s medium (DMEM)/F-12
(Invitrogen, Carlsbad, CA) supplemented with 100 U/mL
penicillin, 100 g/mL streptomycin, 50 g/mL ascorbic acid,
250 ng/mL fungizone, 5 lg/mL insulin (bovine pancreas),
0.4 ng/mL hydrocortisone (all reagents from Sigma-
Aldrich, St. Louis, MO, USA ), and 10% heat-inactivated
FBS St. Louis, MO, USA (Invitrogen, Carlsbad, CA, USA).
Some assays were performed using also human gingival
fibroblasts (GF) which were obtained from biopsies of
healthy gingiva [21]. They were cultured in DMEM
supplemented with 100 U/mL penicillin, 100 g/mL strepto-
mycin, 50 lg/mL ascorbic acid, 250 ng/mL fungizone,
1 mmol/L sodium pyruvate, and 10% heat-inactivated
FBS. Other assays included also carcinoma-associated
fibroblasts derived from a specimen of tongue SCC. The
explants that had an outgrowth of cells with fibroblastic
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(elongated) morphology were selected and isolated with
clonal rings, and the outgrowth of cells was trypsinized
and subsequently cultured in fibroblast routine culture
medium (same as above). These cells, named CaDEC12,
were characterized at passage 3 for the expression of
lineage-specific markers by flow cytometry and immuno-
histochemistry. They expressed the fibroblast markers vi-
mentin (98.67% positive cells) and platelet-derived growth
factor receptor (PDGFR)-B (97.60% cells) and were nega-
tive for epithelial (epidermal surface antigen [ESA] 0.09%
positive cells), endothelial (CD31 0.65% positive cells),
and hematopoietic (CD45 0.25% positive cells) lineage-
specific markers. Very low levels of the pericyte/mesenchy-
mal stem cell marker CD146 (1.48% positive cells) were
detected. In addition, TP53 (exons 5–9) mutation analysis
had been performed using genomic DNA, and it revealed
that CaDEC12 fibroblastic cells were harboring wt p53
while the epithelial cells derived from the same tumor
showed a p53 mutation in exon 7 (codon 772 G>A).
In all monoculture assays (HSC-3 or GF), 3–4 9 105
cells were cultured on the top of myoma tissue for
14 days. In the coculture assays, 2–3 9 105 HSC-3 cells
were first mixed with 4 9 105 GFs or CaDEC12 cells and
then cultured on myoma tissue for 14 days.
The same assays of mono- and cocultures that had
been performed on the myoma model were also
performed on rat type I collagen gel for an identical per-
iod of time which served as controls, as previously
described [19].
All experiments of the myoma and collagen assays are
listed in Table 1.
Immunohistochemical staining
Serial sections were routinely processed as previously
described for the human sections. At the end of the cul-
ture, the organotypic and collagen culture specimens were
fixed overnight in 4% neutral-buffered formalin and
Table 1. Antibodies for immunostains of the in vitro three-dimensional myoma and collagen gel assays.
Investigated
pathways Markers
Clone, working
procedure Manufacturer
Exosomal markers TGF-b Polyclonal, 1:25, overnight, citrate buffer pH 6,
pressure cooker
Acris, Herford, Germany
TSG 101 Polyclonal, 1:30, overnight, EDTA pH 9,
pressure cooker
Proteintech Group, Chicago, IL
CAFs a-SMA Clone 1A4, 1:100, 60 min; citrate buffer, pH 6,
microwave at 92°C
Dako A/S, Denmark
Production and
maintenance of
inflammation
IL-1a Polyclonal, 1:100, overnight, no antigen retrieval
procedure needed
Acris, Herford, Germany
IL-8 Polyclonal, 1:50, overnight, no antigen
retrieval procedure needed
Proteintech Group, Chicago, IL
IL-1R1 (CD121A) Polyclonal, 1:50, overnight, EDTA pH 9, pressure
cooker
Acris, Herford, Germany
NF-kB Polyclonal, NF-kB/p65 1:500, overnight, citrate
buffer pH 6, pressure cooker
Alexis Biochemical San Diego, CA
CXCL12 (SDF-1a) Clone 79018, 1:50, overnight, EDTA pH 9,
pressure cooker
R&D Systems, Minneapolis, MN
CXCR4 Clone 44716, 1:50, overnight, EDTA pH 9,
pressure cooker
R&D Systems, Minneapolis, MN
CD80 Clone 1G10, 1:50, overnight, citrate buffer pH 6,
pressure cooker
Abcam, Cambridge, U.K.
Foxp3 Clone mAbcam 22510, 1:50, overnight, EDTA pH 9,
pressure cooker
Abcam, Cambridge, U.K.
EMT (double-stain) Pan-cytokeratin (DAB) AE1/AE3 (mouse), 1:50, overnight, citrate buffer pH 6,
pressure cooker
–Color reaction: DAB, 10 min
Zymed/Invitrogen, Carlsbad, CA
Twist (fast red) Polyclonal (rabbit), 1:50, overnight, citrate buffer pH 6,
pressure cooker
–Color reaction: permanent AP-red chromagen, 10 min
Zytomed, Berlin, Germany
Secondary antibody: HRP-AP rabbit, 45 min, room
temperature
Innovex Biosciences, Richmond, CA
CAF, cancer-associated fibroblasts; EMT, epithelial–mesenchymal transition; TGF-b, transforming growth factor-b; IL, interleukin; NF-kB, nuclear
factor kappa-B; a-SMA, alpha smooth muscle actin; DAB, 3,3-diamino benzidine.
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embedded in paraffin. Six-micron-thick sections
were deparaffinized and immunostained with various
antibodies, as detailed in Table 1. For double immuno-
staining, the sections were exposed simultaneously to
both primary antibodies and then to the second antibody,
followed by staining with DAB for identification of the
cytokeratin reaction (brown color) and by AP-red chro-
mogen (red–purple color) for the identification of twist
reaction.
TSG101 was used to identify tumor-derived exosomes,
known to carry signals to induce their transdifferentiation
of stromal fibroblasts into CAFs [22]. One of these signals
was transforming growth factor-b (TGF-b) [23]. a-SMA
was used to identify possible formation of CAF-like cells
around the HSC-3 clusters.
Twist, a key marker of the epithelial–mesenchymal
transition (EMT) process [8], is assumed to be involved in
the emergence of CAF-like cells from carcinoma cells.
Therefore, we attempted to identify HSC-3 cells positive
either for both cytokeratin and twist or HSC-3 cells positive
only for twist, implying loss of epithelial differentiation.
Interleukin-1a (IL-1a), IL-1R1, IL-8, and NF-jB are all
known to have reciprocal interactions. IL-1 can induce
expression of NF-jB through IL-8, NF-jB induces expres-
sion of IL-1a, and interleukin-1 receptor 1 (IL-1R1) serves
as the receptor through which NF-jB activates its down-
ward cascade of intracellular effects [24]. CXCL12/SDF-1
(produced mainly by inflammatory cells) and its receptor,
CXCR4 (expressed mainly by the tumor cells), were
selected for their role in tumor migration and invasion
[25]. Two sets of assays were examined for each mono-
culture or coculture of the myoma model and controls.
Immunomorphometry
Assessment of the immunostains was performed semi-
quantitatively on a scale of 0 to 5, where 0 = no staining,
1 = staining of weak intensity in <50% cells, 2 = weak
but extensive (>50% cells) staining, 3 = strong staining in
<50% cells, and 4 = strong staining in >50% cells. The
HSC-3 and, whenever applicable, the myoma cells or
fibroblasts in the control assays were assessed. This
semi-quantitative assessment attempted to give a general
overview of the staining patterns in each type of in vitro
assay and, as such, was not further processed by statistical
analysis. The results of double immunostaining of the
sections by twist and cytokeratin were solely described
qualitatively.
Statistical analysis
Statistical tests included Pearson’s correlations crosstabs
and survival analysis.
Univariate analysis was performed using the Kaplan–
Meier method, and significance was confirmed by the
log-rank test. Multivariate analysis was done using the
Cox’s proportional hazards regression model by forward
variable selection that employed likelihood ratio criteria
and included those covariates that showed significant
associations with recurrence or survival by the univariate
analysis. All statistical analyses were done using SPSS,
version 15 (SPSS Inc., Chicago, IL), and the significance
level was set at P < 0.05.
Results
Human sections of MT cancer
Morphometrical density of the inflammatory cells
The most frequently encountered pattern of inflammatory
infiltrate was dense but noncontinuous (35 cases, 54.7%)
followed by limited-to-absent (17 cases, 26.5%) and then
dense and continuous (12 cases, 18.8%) (Fig. 1a–c).
Types of inflammatory cells: frequency and
correlations
The pan T-cell lymphocytes as a group comprised about
half of the inflammatory infiltrate (54 ± 13%). When ana-
lyzed with respect to separate T-cell phenotypes, CD4+ cells
(36.5 ± 14%) were more abundant than CD8+ cells
(18 ± 15%). Mature macrophages of the CD68+ phenotype
(47 ± 27%) were almost as frequent as the T cells. Plasma
cells (33 ± 16%) and B-cell lymphocytes (26 ± 14%) were
less common than the pan T cells and macrophages. Cells
with a CD163+ phenotype were frequent (40 ± 26%), and
those with a CD80+ phenotype were abundant (77 ± 16%).
High-Foxp3 cases (77.8%) were more common than the
low-Foxp3 cases (32.2%). It should be noted that the sum
of percentages of the various immune cells may be higher
than 100% as there are cells that can express markers char-
acteristic to more than one cell phenotype; for example, B
cells may also be CD138 positive [26] and macrophages
may be CD4 positive (Fig. 1d–m) [27].
NF-jB expression (Fig. 1n) was frequent in the inflam-
matory cells (85 ± 8%), and it was inversely correlated
with the frequency of the pan T cells (P = 0.003,
r = 0.45), the CD8+ cells (P = 0.005, r = 0.45), the
CD4+ cells (P = 0.041, r = 0.32), and the plasma cells
(P = 0.025, r = 0.35).
CAFs: frequency and correlations
Cases with a low-to-intermediate density of CAFs
(n = 35, 68.6%) were more frequent than CAF-rich cases
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(a) (b) (c)
(d) (e)
(g) (h)
(f)
(i) (j) (k)
(l) (m) (n)
Figure 1. (a) Density of the inflammatory infiltrate with a dense and continuous pattern, (b) a dense but discontinuous pattern, and (c) a lack of
inflammatory infiltrate (hematoxylin and eosin, original magnification 409). (d) Samples of specific types of inflammatory cells comprised pan T
lymphocytes, (e) CD4 lymphocytes, (f) CD8 lymphocytes, (g) B lymphocytes, (h) plasma cells, arrows (positive immunostaining also seen in the
tumor islands), (i) CD68 macrophages, (j) CD163 macrophages, (k) CD163 stromal cells (arrows), (l) regulatory T cells (Foxp3-positive), and
(m) CD80-positive cells. Nuclear NF-kB was present in both the tumor cells and the inflammatory cells (n). Photomicrographs (d–n) were at 1009
original magnification with the exception of (m), which was at 2009.
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(n = 16, 31.4%). CAF density was inversely correlated
with the density of the inflammatory infiltrate (P = 0.01)
and positively correlated with the cumulative CD163+
CD80+ Foxp3+ score (P = 0.01).
Immunoexpression of inflammatory markers by
the tumor cells
Expression of CD80 was abundant on the tumor cells
(82 ± 13%). NF-jB expression was also frequent in the
tumors (87 ± 7%). The expression of NF-jB in the
inflammatory cells was positively correlated with that
within the tumor (P < 0.001, r = 0.55)
Protumorigenic inflammatory infiltrate and CAFs:
associations with clinical outcomes
Univariate analysis demonstrated that a high Foxp3 score
had a negative impact on recurrence (P = 0.026)
(Fig. 2a), while the density of the inflammatory infiltrate
as well as the other individual types of inflammatory cells
and the expression of NF-jB had no impact on either
recurrence or patient survival (P > 0.05). The cumulative
high CD163+ CD80+ Foxp3+ score had a negative influ-
ence on recurrence (P = 0.006) (Fig. 2b). A CAF-rich
score had a negative impact on recurrence (P = 0.001)
(Fig. 2c) and was associated with poor survival
(P = 0.002) (Fig. 2d).
Multivariate analysis of the associations between CAFs
and the inflammatory protumorigenic inflammatory
components and clinical outcomes included parameters
of CAFs, Foxp3, and the cumulative CD163+ CD80+
Foxp3+ score. The results for recurrence showed that
CAF-rich cases had a hazard ratio (HR) of 4.1 (95% con-
fidence interval [CI] 1.3–12.8, P = 0.012) compared with
CAF poor-to-intermediate; high CD163+ CD80+ Foxp3+
score had an HR of 2.9 (95% CI 1.03–8.6, P = 0.043)
versus low CD163+ CD80+ Foxp3+ score. The results for
survival showed that the CAF-rich score had an HR of
6.7 (95% CI 1.9–23.7, P = 0.003) compared with the CAF
poor-to-intermediate score.
In vitro three-dimensional myoma
organotypic model
As previously described, all carcinomas cultured on top
of myomas generally exhibited invasion of varying
depths into the smooth muscle tissue mass, while those
cultured over collagen gels were only minimally invasive
[19]. Notably, tumor islands that invaded into the mus-
cle bundles were usually separated from them by an
acellular, collar-like, collagenized area (Fig. 3a and b;
Table 2).
HSC-3 cells were extensively (>50%) stained for
TSG101 in the myoma monocultures and cocultures and
the staining was of strong-to-weak intensity (Fig. 3c
and d). Similar to TSG101, HSC-3 cells were diffusely
and usually strongly positive for TGF-b (Fig. 3f and g).
The myoma cells and other microenvironmental cells
were diffusely stained, but usually at a weaker intensity
than that of the HSC-3 cells for both TSG101 and TGF-b.
Both HSC-3 cells and fibroblasts yielded an extensive and
strong staining for TSG101 and TGF-b in the collagen
cultures (Fig. 3e and h).
Special attention was paid to the immediate periphery
of the HSC-3 cells when examining a-SMA staining in the
myoma assays. The SMA-positive, delicate, spindle-shaped
cells surrounding the HSC-3 infiltrating nests/clusters were
found exclusively in the cocultures of myoma and HSC-3
cells and in those of myoma, HSC-3, and CaDEC12 cells.
The a-SMA-positive cells were arranged in one or more
concentric layers closely around the tumor (Fig. 3i and j).
This pattern was similar to the CAF and tumor interre-
lations seen in the human sections. Using double immu-
nostaining with pan-cytokeratin and twist, we found that
the HSC-3 cells cultured on top of myomas exhibited only
partial cytokeratin immunoreactivity (brown color), while
the invasive islands were predominantly negative, with
only occasional remnants of cytokeratin. Twist expression
was occasionally observed in HSC-3 cell layers on top of
myomas (purple–red color), and it was predominant
within the invading tumor islands concomitantly with the
disappearance of cytokeratin. Interestingly, in sections and
locations with a-SMA-positive CAF-like cells, we also
identified delicate, spindle-shaped cells at the periphery of
the invading tumor islands or closely surrounding them
that were either positive to both cytokeratin and twist in
the HSC-3-myoma monocultures or, alternatively, only
to twist in the HSC-3-CaDEC12-myoma cocultures
(Fig. 3l–m). No a-SMA-stained cells were detected in the
collagen cultures. The HSC-3 cells were strongly positive
for cytokeratin and twist in these assays (Fig. 3n). Even
some downward anatomizing extensions of the HSC-3
cells retained a strong double staining with cytokeratin
and twist and were not found to be only twist positive,
unlike in the myoma model.
The cytokines IL-1a and IL-8 usually exhibited diffuse
and strong expression in the HSC-3 cells (partly also
exhibiting a nuclear location) in the myoma assays. IL-1a
was negative and IL-8 was diffusely and weakly positive
in the surrounding stromal cells. NF-jB, the transcription
factor that has a reciprocal relation with the expression of
the IL-8 gene and its protein product [25, 28, 29], was
diffusely and strongly positive in the HSC-3 cells and less
so in the myoma and other stromal cells. In addition, the
IL-1 receptor, IL-1R1, was diffusely and strongly positive
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in the HSC-3 cells and in the myoma and other stromal
cells. Both the HSC-3 cells and fibroblasts were diffusely
and strongly positive for IL-1a, IL-8, IL-1R1, and NF-jB
in the collagen assays. Examples of the immunostaining
pattern of the examined cytokines are illustrated in
Figure 4.
CXCR4 in both the myoma model and the collagen assay
was usually diffusely and strongly positive in both the HSC-
3 and stromal cells. CXCL12, the CXCR4 ligand, CD80 and
Foxp3 were either absent or had a limited expression in both
the myoma and collagen assays in the HSC-3 cells as well as
in the other types of surrounding cells.
Discussion
The uniqueness of this study lies in its multifactorial anal-
ysis of the TME components in MT cancer that encom-
pass both the inflammatory infiltrate and CAFs. We
investigated the density of the overall tumor-associated
inflammatory infiltrate and examined a wide panel of
different types of inflammatory cells with special emphasis
on those with an anti-inflammatory/protumorigenic
phenotype. Furthermore, we analyzed the relationship
between the inflammatory infiltrate and CAFs and their
correlations with clinical outcomes.
The present results supported those of our previous
studies which showed that a high frequency of CAFs in
MT cancer was associated with poor clinical outcomes [6,
7]. We also found that a high frequency of CAFs was
inversely correlated to the extent of the overall inflamma-
tory infiltrate, suggesting that, unlike CAFs, the inflam-
matory infiltrate is positively associated with clinical
outcomes, in agreement with the results of other studies
[14, 15]. However, examination of known protumorigenic
components of the inflammatory infiltrate, such as regula-
tory T cells (Foxp3), TAM2 (CD163+) cells, and regula-
tory T-cell-inducing immune cells (CD80+), revealed a
negative impact of these cells on disease recurrence,
similar to CAFs. This finding indicates that, in terms of
prognosis, the assessment of the intensity of the overall
TME-related inflammatory infiltrate should always be
followed by assessment of the density of specific pro-
tumorigenic components.
It has been recently shown that signals from cancer
cells can be transmitted to the inflammatory cells via exo-
somes [30]. Exosomes can exert an inhibiting effect on
the function of T cells and on the differentiation and
maturation of antigen-presenting cells from their precur-
sor cells. In addition, they are able to increase the number
and/or enhance the activity of immunosuppressive/protu-
morigenic cells, including myeloid-derived suppressor
cells and regulatory T cells, resulting in suppression of
the immune surveillance.
The present in vitro myoma and collagen assays showed
a high expression of exosomal-associated markers (i.e.,
TSG101, TGF-b) in the HSC-3 cells and, to a lesser extent,
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Figure 2. (a) Kaplan–Meier analysis for
locoregional recurrence by Foxp3. (b) Kaplan–
Meier analysis for locoregional recurrence by
the cumulative score of CD163+ CD80+ Foxp3+.
(c) Kaplan–Meier analysis for locoregional
recurrence by CAF. (d) Kaplan–Meier analysis
for overall survival by CAF scores.
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Figure 3. (a and b) Myoma model and collagen assay. Hematoxylin and eosin stain shows a collagenous “collar-like” area that surrounds the
tumor islands (arrows) that invade into the smooth muscle tissue of the myoma (M) (original magnification 2009). (c) TSG101 in the myoma
model shows a strong and diffuse staining of the superficial lining and deeply invading tumor islands/clusters (original magnification 1009).
(d) The stromal cells surrounding the tumor island are also TSG101 positive when seen at a higher magnification (original magnification 4009).
(e) Both the HSC-3 cells and fibroblasts are TSG101 positive in the collagen assay (original magnification 1009). (f and g) TGF-b immunostain in
the myoma assay (original magnification 1009 and original magnification 4009, respectively) and (h) in the collagen assay (original magnification
1009) exhibit a similar pattern of expression as TSG101. (i) a-SMA staining in a sample of monoculture: a tumor island is surrounded at its
periphery by delicate, spindle-shaped a-SMA-positive cells (arrows). (j) A sample of coculture of HSC-3 cells and CaDEC cells: small invading tumor
islands (arrows) are closely surrounded by concentric layers of a-SMA-positive cells. (k) No a-SMA-positive cells were found in the collagen assay
(i, j, and k, original magnification 4009). (l) Double immunostaining with pan-cytokeratin (CK) (brown) and twist (red–purple): the same field as
illustrated in (i), shows that those a-SMA-positive cells are both pan-CK and twist positive. (m) The same field as illustrated in (j) shows that those
cells positive for a-SMA are twist positive. (n) No stromal cells were seen at the tumor–stroma interface in the collagen assay, as was the case for
(k). (l, m, and n, original magnification 4009).
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in the stromal cells. This is in accordance with a recent
study, in which the cancer cells were shown to release
TGF-b-coated exosomes into the microenvironment [22].
It can be assumed that exosomes exert their effects in both
autocrine and paracrine routes. The secreted exosomes
can be taken up by the cancer cells via the autocrine route
where TGF-b activates the Akt-Smad cascade and induces
many gene transcription sites, including the gene responsi-
ble for the expression of a-SMA [22]. Functional and
morphological alterations within the original epithelial
cancer cells may ultimately occur. Indeed, our in vitro
model enabled us to demonstrate the presence of cells sur-
rounding the periphery of some invading tumor islands
that showed remnants of cytokeratin expression, indicat-
ing their epithelial origin. It concomitantly revealed that
they were predominantly twist positive, implicating these
cells in the EMT process. Furthermore, the availability of
serial sections enabled us to conclude that these positively
double-immunostained cytokeratin and twist cells co-
incided with spindle-shaped a-SMA-positive cells. Identifica-
tion of the HSC-3 cells assumed to have undergone EMT
at the margins of the invasive tumor in the myoma model
can be explained in terms of these cells being subject to
microenvironmental stimuli distinct from those received
by cancer cells located in the cores of the tumor [11].
Moreover, it can be assumed that the cancer cells do not
pass through a complete EMT process, but rather only a
partial one, thereby acquiring new mesenchymal traits
while continuing to express residual epithelial traits [11].
This was shown in the present study, where the peripher-
ally positioned, spindle cells exhibited twist and traits of
cytokeratin. Importantly, these findings were restricted to
the myoma model and they were absent in the collagen
assay, emphasizing the superiority and uniqueness of the
former to create conditions that mimic the natural TME.
TGF-b-coated exosomes are able to induce the trans-
formation of the stromal cells to a-SMA-expressing cells
[22] therefore constituting the paracrine route of action
of the exosomes. Our in vitro study showed that HSC-3-
derived exosomes probably induced the expression of
a-SMA in the CaDEC cells, which subsequently resembled
CAF-like cells, both morphologically (spindle-shaped) and
spatially (subtle concentric cells surrounding the tumor
nests/clusters). Our serial sections showed that the
a-SMA-positive cells in the HSC-3-CaDEC cocultures
were usually twist positive and CK negative. Moreover,
the paracrine route of exosomal TGF-b can also be
related to the modulation of the extracellular matrix and
emergence of fibrotic tissue that always accompanied the
invading tumor islands and that separated them from the
bundles of smooth muscles of the myoma, possibly indi-
cating that exosomal TGF-b can regulate fibrogenesis in
Table 2. In vitro immunoreactivity of the HSC-3 cell line and the stromal components.
TGS101 TGF-b
a-SMA
IL-1a IL-8 NF-kB CXCR4 CXCL12 CD80 Foxp3
T F/M T F/M F/M T F/M T F/M T F/M T F/M T F/M T F/M T F/M
Myoma 2 1 * 0 2nc 2 4 0 0 0
4 1 * 0 2nc 1 4 0 0 0
Myoma + GF 2 1 *  2nc 3 4 0 0 0
4 2 * 0  3 4 0 0 0
Myoma + HSC-3 4 4 4 1 *, CAF 1nc 0 4cn 2nc 4 2 4 4 0 0 4 0 0 0
4 2 4 2 *, CAF 4nc 0 2cn 2cn 4 2 4 4 0 0 3 0 0 0
Myoma + HSC-3 + GF 2 1 4 2 * 4nc 0 4nc 2c 4 1 4 4 0 0 4  0 
2 2 2 1 * 4nc 0 4cn 4nc 4 2 2 4 0 0 4 0 0 0
Myoma + HSC-3 + CaDEC 4 2 4 2 *, CAF 4nc 0 4cn 2cn 4 2 4 4 1 0 1 0 1 0
2 2 2 1 *, CAF 4nc 0 4cn 2c 4 2 4 4 1 0 2 0 0 0
Collagen + GF 4 4 0 2c 4nc 4 4 0 0 0
4 2 0 4c 4cn 4 4 1 3 2
Collagen + HSC-3 + GF 4  4  0 4c 4nc 4cn 4cn 4  4  0 0 2  1 1
4 4 4 4 0 4c 4c 4n 4c 2 1 4 4 0 0 1 1 1 1
Collagen + HSC-3 + GF 4 4 4 4 0 4c 4cn 4cn 4cn 4 4 4 4 0 0 2 2 2 2
4 4 4 4 0 4c 4c 4cn 4cn 4 4 2 2 0 0 4 3 2 2
The numbers refer to the scoring system (0 = no staining, 1 = staining of weak intensity in <50% cells, 2 = weak but extensive [>50% cells]
staining, 3 = strong staining in <50% cells, and 4 = strong staining in >50% cells).
IL-1R1 (CD121A) staining was positive in all examined sections with a score of 4 (see text) in the HSC-3 cells as well as in the fibroblasts/myoma
cells and therefore was not included in this table.
T, tumor; F/M, fibroblasts/myoma cells; GF, gingival fibroblasts; CaDEC12, CAF cell line; c, cytoplasmic staining; n, nuclear staining; cn, cyto-
plasmic staining more frequent than nuclear staining; nc, nuclear staining more frequent than cytoplasmic staining; (), no staining; *, the myoma
smooth muscle cells were positive.
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order to facilitate tumor migration and invasion [31, 32].
In a recent review, it has been pointed out that the degree
of the rigidity of the extracellular matrix is associated
with the mechanical stress and interstitial flow in the
tumor stroma, which is used by the CAFs as guidance
tracks to direct cancer cell migration [33]. The extracellu-
lar matrix rigidity together with an impaired vascular and
lymphatic network contribute to an increase in the inter-
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Figure 4. Immunohistochemical stains of the
myoma model and collagen assay for IL-1a (a
and b), IL-8 (c and d), NF-kB (e and f), IL-1R1
(g and h), and CXCR4 (i and j) (a, c, e, g, and
i, original magnification 409; b, d, f, h, and j,
original magnification 1009).
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stitial fluid pressure that ultimately results in a reduced
delivery of chemotherapeutics [33].
The myoma model also enabled us to show high expres-
sions of cytokines, such as IL-1a, IL-1R1, IL-8, and NF-jB,
which are all known to have reciprocal interactions. IL-1 can
induce expression of NF-jB through IL-8, NF-jB induces
expression of IL-1a, and IL-1R1 serves as the receptor
through which NF-jB activates its downward cascade of
intracellular effects. Altogether, these cytokines have the
potential to promote tumor proliferation, growth, and inva-
sion [24, 25, 28, 29, 33]. For example, the strong expression
of CXCR4 that we found in the HSC-3 cells could have been
induced by stromal TGF-b, the latter being necessary for the
continued expression of CXCR4 [13]. Expression of CXCR4
in cancer cells generally activates the Akt-signaling pathways
that are responsible for cellular invasion and proliferation.
Interestingly, the expression of CXCR4 within the cancer
cells was shown to also be induced by NF-jB [13]. Our in
vitro study demonstrated strong expression of both CXCR4
and NF-jB within the HSC-3 cells. The existence of the cyto-
kine crosstalk between cancer cells and CAFs had already
been investigated in in vitro assays of oral SCC [34] and
pancreatic ductal adenocarcinoma (PDAC) [29]. In those
studies, cancer-derived IL-1a played a key role in inducing
CAFs to release factors with functions in tumor migration
and invasion (i.e., IL-1a, IL-8, IL-6, and others).
In summary, the clinicopathological correlations that
emerged from this investigation highlighted significant
associations between TME components (i.e., inflamma-
tory protumorigenic cells and CAFs) and poor clinical
outcomes in terms of recurrence and shortened survival.
Our culturing of tongue cancer cells on a three-
dimensional myoma organotypic model that mimics TME
revealed the presence of cancer-derived exosomes, the
EMT process, the acquisition of a CAF-like phenotype by
fibroblasts, and reciprocal interrelations between different
cytokines. Collectively, these results suggest the presence
of molecular crosstalk between cancer cells and TME
components in MT cancer. New therapeutic modalities to
target this crosstalk should be developed in order to
improve the prognosis of MT cancer patients.
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